Notch signaling in vascular development and physiology

Development

Volumn 134, Issue 15, 2007, Pages 2709-2718

  Gridley, Thomas ^a  

^a JACKSON LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; DELTA LIKE LIGAND 4 ANTIBODY; NOTCH RECEPTOR; NOTCH3 RECEPTOR; RECOMBINANT DELTA LIKE LIGAND 4 PROTEIN; UNCLASSIFIED DRUG; VASCULOTROPIN A; VASCULOTROPIN A ANTIBODY; VASCULOTROPIN ANTIBODY;

ANGIOGENESIS; ANTINEOPLASTIC ACTIVITY; ARTERIOVENOUS MALFORMATION; ARTERY; CADASIL; CANCER; CANCER INHIBITION; CARDIOVASCULAR DISEASE; CELL DIFFERENTIATION; CLINICAL TRIAL; DRUG POTENTIATION; DRUG TARGETING; ENDOTHELIUM CELL; GENE MUTATION; HUMAN; METABOLIC REGULATION; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; SOLID TUMOR; TISSUE DIFFERENTIATION; TUMOR VASCULARIZATION; VASCULAR SMOOTH MUSCLE; VEIN;

ANIMALS; ARTERIES; BLOOD VESSELS; CADASIL; CARDIOVASCULAR DISEASES; CELL DIFFERENTIATION; ENDOTHELIAL CELLS; HUMANS; MODELS, BIOLOGICAL; MUSCLE, SMOOTH, VASCULAR; NEOPLASMS, VASCULAR TISSUE; NEOVASCULARIZATION, PATHOLOGIC; RECEPTORS, NOTCH; SIGNAL TRANSDUCTION; VEINS;

VERTEBRATA;

EID: 34548164780     PISSN: 09501991     EISSN: None     Source Type: Journal    
DOI: 10.1242/dev.004184     Document Type: Review

References (99)

1. Barsi, J. C., Rajendra, R., Wu, J. I. and Artzt, K. (2005). Mind bomb1 is a ubiquitin ligase essential for mouse embryonic development and Notch signaling. Mech. Dev. 122, 1106-1117.
2. Braverman, A. C., Guven, H., Beardslee, M. A., Makan, M., Kates, A. M. and Moon, M. R. (2005). The bicuspid aortic valve. Curr. Probl. Cardiol. 30, 470-522.
3. Bray, S. J. (2006). Notch signalling: a simple pathway becomes complex. Nat. Rev. Mol. Cell Biol. 7, 678-689.
4. Byrne, A. M., Bouchier-Hayes, D. J. and Harmey, J. H. (2005). Angiogenic and cell survival functions of vascular endothelial growth factor (VEGF). J. Cell. Mol. Med. 9, 777-794.
5. Campos, A. H., Wang, W., Pollman, M. J. and Gibbons, G. H. (2002). Determinants of Notch-3 receptor expression and signaling in vascular smooth muscle cells: implications in cell-cycle regulation. Circ Res. 91, 999-1006.
6. Carlson, T. R., Yan, Y., Wu, X., Lam, M. T., Tang, G. L., Beverly, L. J., Messina, L. M., Capobianco, A. J., Werb, Z. and Wang, R. (2005). Endothelial expression of constitutively active Notch4 elicits reversible arteriovenous malformations in adult mice. Proc. Natl. Acad. Sci. USA 102, 9884-9889.
7. Carmeliet, P., Ferreira, V., Breier, G., Pollefeyt, S., Kieckens, L., Gertsenstein, M., Fahrig, M., Vandenhoeck, A., Harpal, K., Eberhardt, C. et al. (1996) Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380, 435-439.
8. Coultas, L., Chawengsaksophak, K. and Rossant, J. (2005). Endothelial cells and VEGF in vascular development. Nature 438, 937-945.
9. Doi, H., Iso, T., Yamazaki, M., Akiyama, H., Kanai, H., Sato, H., Kawai-Kowase, K., Tanaka, T., Maeno, T., Okamoto, E. et al. (2005). HERP1 inhibits myocardin-induced vascular smooth muscle cell differentiation by interfering with SRF binding to CArG box. Arterioscler. Thromb. Vasc. Biol. 25, 2328-2334.
10. Doi, H., Iso, T., Sato, H., Yamazaki, M., Matsui, H., Tanaka, T., Manabe, I., Arai, M., Nagai, R. and Kurabayashi, M. (2006). Jagged1-selective notch signaling induces smooth muscle differentiation via a RBP-Jkappa-dependent pathway. J. Biol. Chem. 281, 28555-28564.
11. Domenga, V., Fardoux, P., Lacombe, P., Monet, M., Maciazek, J., Krebs, L. T., Klonjkowski, B., Berrou, E., Mericskay, M., Li, Z. et al. (2004). Notch3 is required for arterial identity and maturation of vascular smooth muscle cells. Genes Dev. 18, 2730-2735.
12. Dorrell, M. I. and Friedlander, M. (2006). Mechanisms of endothelial cell guidance and vascular patterning in the developing mouse retina. Prog. Retin. Eye Res. 25, 277-295.
13. Duarte, A., Hirashima, M., Benedito, R., Trindade, A., Diniz, P., Bekman, E., Costa, L., Henrique, D. and Rossant, J. (2004). Dosage-sensitive requirement for mouse DII4 in artery development. Genes Dev. 18, 2474-2478.
14. Dubroca, C., Lacombe, P., Domenga, V., Maciazek, J., Levy, B., Tournier-Lasserve, E., Joutel, A. and Henrion, D. (2005) Impaired vascular mechanotransduction in a transgenic mouse model of CADASIL arteriopathy. Stroke 36, 113-117.
15. Ehebauer, M., Hayward, P. and Martinez-Arias, A. (2006a). Notch signaling pathway. Sci. STKE 2006, cm7.
16. Ehebauer, M., Hayward, P. and Martinez-Arias, A. (2006b). Notch, a universal arbiter of cell fate decisions. Science 314, 1414-1415.
17. Ferrara, N. and Kerbel, R. S. (2005). Angiogenesis as a therapeutic target. Nature 438, 967-974.
18. Ferrara, N., Carver-Moore, K., Chen, H., Dowd, M., Lu, L., O'Shea, K. S., Powell-Braxton, L., Hillan, K. J. and Moore, M. W. (1996). Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 380, 439-442.
19. Fischer, A., Schumacher, N., Maier, M., Sendtner, M. and Gessler, M. (2004). The Notch target genes Hey1 and Hey2 are required for embryonic vascular development. Genes Dev. 18, 901-911.
20. Fischer, A., Steidl, C., Wagner, T. U., Lang, E., Jakob, P. M., Friedl, P., Knobeloch, K. P. and Gessler, M. (2007). Combined loss of Hey1 and HeyL causes congenital heart defects because of impaired epithelial to mesenchymal transition. Circ. Res. 100, 856-863.
21. Gale, N. W., Dominguez, M. G., Noguera, I., Pan, L., Hughes, V., Valenzuela, D. M., Murphy, A. J., Adams, N. C., Lin, H. C., Holash, J. et al. (2004). Haploinsufficiency of delta-like 4 ligand results in embryonic lethality due to major defects in arterial and vascular development. Proc. Natl. Acad. Sci. USA 101, 15949-15954.
22. Garg, V. (2006). Molecular genetics of aortic valve disease. Curr. Opin. Cardiol. 21, 180-184.
23. Garg, V., Muth, A. N., Ransom, J. F., Schluterman, M. K., Barnes, R., King, I. N., Grossfeld, P. D. and Srivastava, D. (2005). Mutations in NOTCH1 cause aortic valve disease. Nature 437, 270-274.
24. Gariano, R. F. and Gardner, T. W. (2005). Retinal angiogenesis in development and disease. Nature 438, 960-966.
25. Gerhardt, H., Golding, M., Fruttiger, M., Ruhrberg, C., Lundkvist, A., Abramsson, A., Jeltsch, M., Mitchell, C., Alitalo, K., Shima, D. et al. (2003). VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia. J. Cell Biol. 161, 1163-1177.
26. Gerhardt, H., Ruhrberg, C., Abramsson, A., Fujisawa, H., Shima, D. and Betsholtz, C. (2004). Neuropilin-1 is required for endothelial tip cell guidance in the developing central nervous system. Dev. Dyn. 231, 503-509.
27. Grego-Bessa, J., Luna-Zurita, L., Del Monte, G., Bolos, V., Melgar, P., Arandilla, A., Garratt, A. N., Zang, H., Mukouyama, Y. S., Chen, H. et al. (2007). Notch signaling is essential for ventricular chamber development. Dev. Cell 12, 415-429.
28. Gridley, T. (2003). Notch signaling and inherited disease syndromes. Hum. Mol. Genet. 12 Spec No 1, R9-R13.
29. Hainaud, P., Contreres, J. O., Villemain, A., Liu, L. X., Plouet, J., Tobelem, G. and Dupuy, E. (2006). The role of the vascular endothelial growth factor-delta-like 4 ligand/Notch4-ephrin B2 cascade in tumor vessel remodeling and endothelial cell functions. Cancer Res. 66, 8501-8510.
30. Havrda, M. C., Johnson, M. J., O'Neill, C. F. and Liaw, L. (2006). A novel mechanism of transcriptional repression of p27kip1 through Notch/ HRT2 signaling in vascular smooth muscle cells. Thromb. Haemost. 96, 361-370.
31. Hellstrom, M., Phng, L. K., Hofmann, J. J., Wallgard, E., Coultas, L., Lindblom, P., Alva, J., Nilsson, A. K., Karlsson, L., Gaiano, N. et al. (2007). DII4 signalling through Notch1 regulates formation of tip cells during angiogenesis. Nature 445, 776-780.
32. Herreman, A., Hartmann, D., Annaert, W., Saftig, P., Craessaerts, K., Serneels, L., Umans, L., Schrijvers, V., Checler, F., Vanderstichele, H. et al. (1999). Presenilin 2 deficiency causes a mild pulmonary phenotype and no changes in amyloid precursor protein processing but enhances the embryonic lethal phenotype of presenilin 1 deficiency. Proc. Natl. Acad. Sci. USA 96, 11872-11877.
33. High, F. A., Zhang, M., Proweller, A., Tu, L., Parmacek, M. S., Pear, W. S. and Epstein, J. A. (2007). An essential role for Notch in neural crest during cardiovascular development and smooth muscle differentiation. J. Clin. Invest. 117, 353-363.
34. Huppert, S. S., Le, A., Schroeter, E. H., Mumm, J. S., Saxena, M. T., Milner, L. A. and Kopan, R. (2000). Embryonic lethality in mice homozygous for a processing-deficient allele of Notch1. Nature 405, 966-970.
35. Ilagan, M. X. and Kopan, R. (2007). SnapShot: notch signaling pathway. Cell 128, 1246.
36. Ishiko, A., Shimizu, A., Nagata, E., Takahashi, K., Tabira, T. and Suzuki, N. (2006). Notch3 ectodomain is a major component of granular osmiophilic material (GOM) in CADASIL. Acta Neuropathol. 112, 333-339.
37. Iso, T., Maeno, T., Oike, Y., Yamazaki, M., Doi, H., Arai, M. and Kurabayashi, M. (2006). DII4-selective Notch signaling induces ephrinB2 gene expression in endothelial cells. Biochem. Biophys. Res. Commun. 341, 708-714.
38. Jain, R. K., Duda, D. G., Clark, J. W. and Loeffler, J. S. (2006). Lessons from phase III clinical trials on anti-VEGF therapy for cancer. Nat. Clin. Pract. Oncol. 3, 24-40.
39. Jones, E. A., le Noble, F. and Eichmann, A. (2006). What determines blood vessel structure? Genetic prespecification vs. hemodynamics. Physiology 21, 388-395.
40. Joutel, A., Corpechot, C., Ducros, A., Vahedi, K., Chabriat, H., Mouton, P., Alamowitch, S., Domenga, V., Cecillion, M., Marechal, E. et al. (1996). Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia. Nature 383, 707-710.
41. Joutel, A., Andreux, F., Gaulis, S., Domenga, V., Cecillon, M., Battail, N., Piga, N., Chapon, F., Godfrain, C. and Tournier-Lasserve, E. (2000) The ectodomain of the Notch3 receptor accumulates within the cerebrovasculature of CADASIL patients. J. Clin. Invest. 105, 597-605.
42. Kaestner, K. H., Knochel, W. and Martinez, D. E. (2000). Unified nomenclature for the winged helix/forkhead transcription factors. Genes Dev. 14, 142-146.
43. Kageyama, R., Ohtsuka, T. and Kobayashi, T. (2007). The Hes gene family: repressors and oscillators that orchestrate embryogenesis. Development 134, 1243-1251.
44. Kalaria, R. N., Viitanen, M., Kalimo, H., Dichgans, M. and Tabira, T. (2004) The pathogenesis of CADASIL: an update. J. Neurol. Sci. 226, 35-39.
45. Kokubo, H., Miyagawa-Tomita, S., Nakazawa, M., Saga, Y. and Johnson, R. L. (2005). Mouse hesr1 and hesr2 genes are redundantly required to mediate Notch signaling in the developing cardiovascular system. Dev. Biol. 278, 301-309.
46. Koo, B. K., Lim, H. S., Song, R., Yoon, M. J., Yoon, K. J., Moon, J. S., Kim, Y. W., Kwon, M. C., Yoo, K. W., Kong, M. P. et al. (2005). Mind bomb 1 is essential for generating functional Notch ligands to activate Notch. Development 132, 3459-3470.
47. Krebs, L. T., Xue, Y., Norton, C. R., Shutter, J. R., Maguire, M., Sundberg, J. P., Gallahan, D., Closson, V., Kitajewski, J., Callahan, R. et al. (2000) Notch signaling is essential for vascular morphogenesis in mice. Genes Dev. 14, 1343-1352.
48. Krebs, L. T., Shutter, J. R., Tanigaki, K., Honjo, T., Stark, K. L. and Gridley, T. (2004). Haploinsufficient lethality and formation of arteriovenous malformations in Notch pathway mutants. Genes Dev. 18, 2469-2473.
49. Kume, T., Jiang, H., Topczewska, J. M. and Hogan, B. L. (2001). The murine winged helix transcription factors, Foxc1 and Foxc2, are both required for cardiovascular development and somitogenesis. Genes Dev. 15, 2470-2482.
50. Lacombe, P., Oligo, C., Domenga, V., Tournier-Lasserve, E. and Joutel, A. (2005). Impaired cerebral vasoreactivity in a transgenic mouse model of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy arteriopathy. Stroke 36, 1053-1058.
51. Lamont, R. E. and Childs, S. (2006). MAPping out arteries and veins. Sci. STKE 2006, pe39.
52. Lawson, N. D., Scheer, N., Pham, V. N., Kim, C. H., Chitnis, A. B., Campos-Ortega, J. A. and Weinstein, B. M. (2001). Notch signaling is required for arterial-venous differentiation during embryonic vascular development. Development 128, 3675-3683.
53. Lawson, N. D., Vogel, A. M. and Weinstein, B. M. (2002). sonic hedgehog and vascular endothelial growth factor act upstream of the Notch pathway during arterial endothelial differentiation. Dev. Cell 3, 127-136.
54. Le Borgne, R. (2006). Regulation of Notch signalling by endocytosis and endosomal sorting. Curr Opin. Cell Biol. 18, 213-222.
55. Leslie, J. D., Ariza-McNaughton, L., Bermange, A. L., McAdow, R., Johnson, S. L. and Lewis, J. (2007). Endothelial signalling by the Notch ligand Delta-like 4 restricts angiogenesis. Development 134, 839-844.
56. Li, T., Ma, G., Cai, H., Price, D. L. and Wong, P. C. (2003). Nicastrin is required for assembly of presenilin/gamma-secretase complexes to mediate Notch signaling and for processing and trafficking of beta-amyloid precursor protein in mammals. J. Neurosci. 23, 3272-3277.
57. Limbourg, F. P., Takeshita, K., Radtke, F., Bronson, R. T., Chin, M. T. and Liao, J. K. (2005). Essential role of endothelial Notch1 in angiogenesis. Circulation 111, 1826-1832.
58. Lindner, V., Booth, C., Prudovsky, I., Small, D., Maciag, T. and Liaw, L. (2001). Members of the Jagged/Notch gene families are expressed in injured arteries and regulate cell phenotype via alterations in cell matrix and cell-cell interaction. Am. J. Pathol. 159, 875-883.
59. Liu, Z. J., Shirakawa, T., Li, Y., Soma, A., Oka, M., Dotto, G. P., Fairman, R. M., Velazquez, O. C. and Herlyn, M. (2003) Regulation of Notch1 and DII4 by vascular endothelial growth factor in arterial endothelial cells: implications for modulating arteriogenesis and angiogenesis. Mol. Cell. Biol. 23, 14-25.
60. Lobov, I. B., Renard, R. A., Papadopoulos, N., Gale, N. W., Thurston, G., Yancopoulos, G. D. and Wiegand, S. J. (2007). Delta-like ligand 4 (DII4) is induced by VEGF as a negative regulator of angiogenic sprouting. Proc. Natl. Acad. Sci. USA 104, 3219-3224.
61. Lundkvist, J., Zhu, S., Hansson, E. M., Schweinhardt, P., Miao, Q., Beatus, P., Dannaeus, K., Karlstrom, H., Johansson, C. B., Viitanen, M. et al. (2005) Mice carrying a R142C Notch 3 knock-in mutation do not develop a CADASIL-like phenotype. Genesis 41, 13-22.
62. Mailhos, C., Modlich, U., Lewis, J., Harris, A., Bicknell, R. and Ish-Horowicz, D. (2001). Delta4, an endothelial specific notch ligand expressed at sites of physiological and tumor angiogenesis. Differentiation 69, 135-144.
63. McDaniell, R., Warthen, D. M., Sanchez-Lara, P. A., Pai, A., Krantz, I. D., Piccoli, D. A. and Spinner, N. B. (2006). NOTCH2 mutations cause Alagille syndrome, a heterogeneous disorder of the notch signaling pathway. Am. J. Hum. Genet. 79, 169-173.
64. Moessler, H., Mericskay, M., Li, Z., Nagl, S., Paulin, D. and Small, J. V. (1996) The SM 22 promoter directs tissue-specific expression in arterial but not in venous or visceral smooth muscle cells in transgenic mice. Development 122, 2415-2425.
65. Mohamed, S. A., Aherrahrou, Z., Liptau, H., Erasmi, A. W., Hagemann, C., Wrobel, S., Borzym, K., Schunkert, H., Sievers, H. H. and Erdmann, J. (2006). Novel missense mutations (p.T596M and p.P1797H) in NOTCH1 in patients with bicuspid aortic valve. Biochem Biophys. Res. Commun. 345, 1460-1465.
66. Monet, M., Domenga, V., Lemaire, B., Souilhol, C., Langa, F., Babinet, C., Gridley, T., Tournier-Lasserve, E., Cohen-Tannoudji, M. and Joutel, A. (2007). The archetypal R90C CADASIL-NOTCH3 mutation retains NOTCH3 function in vivo. Hum. Mol. Genet. 16, 982-992.
67. Morrow, D., Scheller, A., Birney, Y. A., Sweeney, C., Guha, S., Cummins, P. M., Murphy, R., Walls, D., Redmond, E. M. and Cahill, P. A. (2005a) Notch-mediated CBF-1/RBP-J{kappa}-dependent regulation of human vascular smooth muscle cell phenotype in vitro. Am. J. Physiol. Cell Physiol. 289, C1188-C1196.
68. Morrow, D., Sweeney, C., Birney, Y. A., Cummins, P. M., Walls, D., Redmond, E. M. and Cahill, P. A. (2005b). Cyclic strain inhibits Notch receptor signaling in vascular smooth muscle cells in vitro. Circ. Res. 96, 567-575.
69. Mukouyama, Y. S., Shin, D., Britsch, S., Taniguchi, M. and Anderson, D. J. (2002). Sensory nerves determine the pattern of arterial differentiation and blood vessel branching in the skin. Cell 109, 693-705.
70. Mukouyama, Y. S., Gerber, H. P., Ferrara, N., Gu, C. and Anderson, D. J. (2005). Peripheral nerve-derived VEGF promotes arterial differentiation via neuropilin 1-mediated positive feedback. Development 132, 941-952.
71. Noguera-Troise, I., Daly, C., Papadopoulos, N. J., Coetzee, S., Boland, P., Gale, N. W., Lin, H. C., Yancopoulos, G. D. and Thurston, G. (2006). Blockade of Dll4 inhibits tumour growth by promoting non-productive angiogenesis. Nature 444, 1032-1037.
72. Noseda, M., McLean, G., Niessen, K., Chang, L., Pollet, I., Montpetit, R., Shahidi, R., Dorovini-Zis, K., Li, L., Beckstead, B. et al. (2004). Notch activation results in phenotypic and functional changes consistent with endothelial-to-mesenchymal transformation. Circ. Res. 94, 910-917.
73. Noseda, M., Fu, Y., Niessen, K., Wong, F., Chang, L., McLean, G. and Karsan, A. (2006). Smooth Muscle alpha-actin is a direct target of Notch/CSL. Circ. Res. 98, 1468-1470.
74. Patel, N. S., Li, J. L., Generali, D., Poulsom, R., Cranston, D. W. and Harris, A. L. (2005). Up-regulation of delta-like 4 ligand in human tumor vasculature and the role of basal expression in endothelial cell function. Cancer Res. 65, 8690-8697.
75. Proweller, A., Pear, W. S. and Parmacek, M. S. (2005). Notch signaling represses myocardin-induced smooth muscle cell differentiation. J. Biol. Chem. 280, 8994-9004.
76. Ridgway, J., Zhang, G., Wu, Y., Stawicki, S., Liang, W. C., Chanthery, Y., Kowalski, J., Watts, R. J., Callahan, C., Kasman, I. et al. (2006). Inhibition of Dll4 signalling inhibits tumour growth by deregulating angiogenesis. Nature 444, 1083-1087.
77. Ruchoux, M. M., Domenga, V., Brulin, P., Maciazek, J., Limol, S., Tournier-Lasserve, E. and Joutel, A. (2003). Transgenic mice expressing mutant Notch3 develop vascular alterations characteristic of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Am. J. Pathol. 162, 329-342.
78. Sainson, R. C., Aoto, J., Nakatsu, M. N., Holderfield, M., Conn, E., Koller, E. and Hughes, C. C. (2005). Cell-autonomous notch signaling regulates endothelial cell branching and proliferation during vascular tubulogenesis. FASEB J. 19, 1027-1029.
79. Sakata, Y., Xiang, F., Chen, Z., Kiriyama, Y., Kamei, C. N., Simon, D. I. and Chin, M. T. (2004). Transcription factor CHF1/Hey2 regulates neointimal formation in vivo and vascular smooth muscle proliferation and migration in vitro. Arterioscler. Thromb. Vasc. Biol. 24, 2069-2074.
80. Scehnet, J. S., Jiang, W., Kumar, S. R., Krasnoperov, V., Trindade, A., Benedito, R., Djokovic, D., Borges, C., Ley, E. J., Duarte, A. et al. (2007). Inhibition of DII4 mediated signaling induces proliferation of immature vessels and results in poor tissue perfusion. Blood 109, 4753-4760.
81. Seo, S., Fujita, H., Nakano, A., Kang, M., Duarte, A. and Kume, T. (2006). The forkhead transcription factors, Foxc1 and Foxc2, are required for arterial specification and lymphatic sprouting during vascular development. Dev. Biol. 294, 458-470.
82. Shibuya, M. and Claesson-Welsh, L. (2006). Signal transduction by VEGF receptors in regulation of angiogenesis and lymphangiogenesis. Exp. Cell Res. 312, 549-560.
83. Siekmann, A. F. and Lawson, N. D. (2007). Notch signalling limits angiogenic cell behaviour in developing zebrafish arteries. Nature 445, 781-784.
84. Sorensen, L. K., Brooke, B. S., Li, D. Y. and Urness, L. D. (2003). Loss of distinct arterial and venous boundaries in mice lacking endoglin, a vascular-specific TGFbeta coreceptor. Dev. Biol. 261, 235-250.
85. Stalmans, I., Ng, Y. S., Rohan, R., Fruttiger, M., Bouche, A., Yuce, A., Fujisawa, H., Hermans, B., Shani, M., Jansen, S. et al. (2002). Arteriolar and venular patterning in retinas of mice selectively expressing VEGF isoforms. J. Clin. Invest. 109, 327-336.
86. Suchting, S., Freitas, C., le Noble, F., Benedito, R., Breant, C., Duarte, A. and Eichmann, A. (2007). The Notch ligand Delta-like 4 negatively regulates endothelial tip cell formation and vessel branching. Proc. Natl. Acad. Sci. USA 104, 3225-3230.
87. Timmerman, L. A., Grego-Bessa, J., Raya, A., Bertran, E., Perez-Pomares, J. M., Diez, J., Aranda, S., Palomo, S., McCormick, F., Izpisua-Belmonte, J. C. et al. (2004). Notch promotes epithelial-mesenchymal transition during cardiac development and oncogenic transformation. Genes Dev. 18, 99-115.
88. Uemura, A., Kusuhara, S., Katsuta, H. and Nishikawa, S. (2006). Angiogenesis in the mouse retina: a model system for experimental manipulation. Exp. Cell Res. 312, 676-683.
89. Uyttendaele, H., Ho, J., Rossant, J. and Kitajewski, J. (2001). Vascular patterning defects associated with expression of activated Notch4 in embryonic endothelium. Proc. Natl. Acad. Sci. USA 98, 5643-5648.
90. van der Loop, F. T., Gabbiani, G., Kohnen, G., Ramaekers, F. C. and van Eys, G. J. (1997). Differentiation of smooth muscle cells in human blood vessels as defined by smoothelin, a novel marker for the contractile phenotype. Arterioscler Thromb. Vasc. Biol. 17, 665-671.
91. Visconti, R. P., Richardson, C. D. and Sato, T. N. (2002). Orchestration of angiogenesis and arteriovenous contribution by angiopoietins and vascular endothelial growth factor (VEGF). Proc. Natl. Acad. Sci. USA 99, 8219-8224.
92. Vogeli, K. M., Jin, S. W., Martin, G. R. and Stainier, D. Y. (2006). A common progenitor for haematopoietic and endothelial lineages in the zebrafish gastrula. Nature 443, 337-339.
93. Wang, W., Campos, A. H., Prince, C. Z., Mou, Y. and Pollman, M. J. (2002). Coordinate Notch3-hairy-related transcription factor pathway regulation in response to arterial injury. Mediator role of platelet-derived growth factor and ERK. J. Biol. Chem. 277, 23165-23171.
94. Wang, W., Prince, C. Z., Hu, X. and Pollman, M. J. (2003). HRT1 modulates vascular smooth muscle cell proliferation and apoptosis. Biochem. Biophys. Res. Commun. 308, 596-601.
95. Warthen, D. M., Moore, E. C., Kamath, B. M., Morrissette, J. J., Sanchez, P., Piccoli, D. A., Krantz, I. D. and Spinner, N. B. (2006). Jagged1 (JAG1) mutations in Alagille syndrome: increasing the mutation detection rate. Hum. Mutat. 27, 436-443.
96. Weinmaster, G. and Kopan, R. (2006). A garden of Notch-ly delights. Development 133, 3277-3282.
97. Xue, Y., Gao, X., Lindsell, C. E., Norton, C. R., Chang, B., Hicks, C., Gendron-Maguire, M., Rand, E. B., Weinmaster, G. and Gridley, T. (1999). Embryonic lethality and vascular defects in mice lacking the Notch ligand Jagged1. Hum. Mol. Genet. 8, 723-730,
98. Zhong, T. P., Rosenberg, M., Mohideen, M. A., Weinstein, B. and Fishman, M. C. (2000). gridlock, an HLH gene required for assembly of the aorta in zebrafish. Science 287, 1820-1824.
99. Zhong, T. P., Childs, S., Leu, J. P. and Fishman, M. C. (2001). Gridlock signalling pathway fashions the first embryonic artery. Nature 414, 216-220.